Group One Trading
ARIA

Group One Trading’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Group One Trading’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-351,100
Closed -$4.37M – 5387
2016
Q4 		$4.37M Sell
351,100
-50,100
-12% -$603K 0.04% 490
2016
Q3 		$5.49M Buy
401,200
+208,000
+108% +$2.09M 0.06% 378
2016
Q2 		$1.43M Buy
193,200
+124,300
+180% +$933K 0.02% 1005
2016
Q1 		$440K Sell
68,900
-551,800
-89% -$3.09M 0.01% 1775
2015
Q4 		$3.88M Sell
620,700
-10,500
-2% -$68.9K 0.05% 481
2015
Q3 		$3.69M Sell
631,200
-254,200
-29% -$1.96M 0.05% 469
2015
Q2 		$7.32M Buy
885,400
+101,300
+13% +$896K 0.1% 212
2015
Q1 		$6.46M Sell
784,100
-543,700
-41% -$4.02M 0.1% 185
2014
Q4 		$9.12M Buy
1,327,800
+502,000
+61% +$3.14M 0.14% 140
2014
Q3 		$4.46M Buy
825,800
+27,800
+3% +$162K 0.07% 340
2014
Q2 		$5.08M Sell
798,000
-579,400
-42% -$3.98M 0.08% 290
2014
Q1 		$11.1M Sell
1,377,400
-371,400
-21% -$2.89M 0.19% 91
2013
Q4 		$11.9M Buy
1,748,800
+1,536,600
+724% +$8.3M 0.18% 78
2013
Q3 		$3.9M Buy
212,200
+125,300
+144% +$2.43M 0.07% 283
2013
Q2 		$1.52M Buy
+86,900
New +$1.54M 0.04% 570

Other funds holding ARIA

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Group One Trading's ARIA Position: Q2 2016 in Review

Group One Trading sold out of Ariad Pharmaceuticals Inc (ARIA) in Q2 2016, closing a stake of 48,395 shares — an estimated $363K sold.

Group One Trading first reported a position in ARIA in Q2 2013 and held it in 12 quarters. The position peaked at $6.67M in Q4 2013. 182 funds tracked by Wall St. Rank hold ARIA as of Q2 2016.

  • Group One Trading reported no remaining Ariad Pharmaceuticals Inc position as of Q2 2016 after selling out during the quarter.
  • Group One Trading sold 48,395 Ariad Pharmaceuticals Inc shares in Q2 2016, an estimated $363K.
  • Group One Trading first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 12 quarters.
  • Group One Trading's Ariad Pharmaceuticals Inc position peaked at $6.67M in Q4 2013.
  • 182 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q2 2016.

Based on Group One Trading's 13F filing for Q2 2016, filed 12 Aug 2016.